Article Information
History
- September 26, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Annalisa V. Piccorelli, Ph.D., Senior Collaborative Biostatistician1,* and
- Jerry A. Nick, M.D., Internist, Professor, Director of Adult Cystic Fibrosis Program2
- 1Division of Biostatistics, Kaiser Permanente Washington Health Research Institute, 1730 Minor Avenue, Seattle, WA 98101, USA
- 2Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, 1400 Jackson St., Denver, CO 80206, USA
- ↵* Corresponding author; email: annie.v.piccorelli{at}kp.org
Author Contributions: Dr. Piccorelli wrote the original draft of the manuscript. Drs. Piccorelli and Nick reviewed and edited the manuscript and both authors approve of the the final version to be published. Dr. Piccorelli formulated the study goals, methodology, and conducted the formal analyses and visualization of the data. Dr. Piccorelli had full access to all of the data and takes responsibility for the accuracy of the data analyses.
Posted September 26, 2023.
MODELING CYSTIC FIBROSIS PATIENT PROGNOSIS: NOMOGRAMS TO PREDICT LUNG TRANSPLANTATION AND SURVIVAL PRIOR TO HIGHLY EFFECTIVE MODULATOR THERAPY
